Nambu H, Anakura M, Tanakawa N, Sawada H
Hokkaido Igaku Zasshi. 1979 May;54(3):253-63.
Diseases which manifest with the respiratory distress in the newborn include 1) respiratory diseases-IRDS, type II RDS, neonatal asphyxia, and MAS etc. 2) anemia, CHD 3) CNS and 4) metabolic diseases. Among these, IRDS has high mortality rate because of the lack of the pulmonary surfactant and immaturity of respiratory center, and has many difficult problems in terms of its prevention and respiratory management. The points of its respiratory management are as follows: 1) Estimation of the level of arterial oxygen ation-this is the most important point. It has become possible, these days, to monitor continuous oxygenation using a transcutaneous oxygen electrode. 2) Knowledge of the physiology & management of apnea, and monitoring of heart rate and respiration. 3) Correction of acidosis & anemia and the nutritional supply by the intraveonous fluid administration. 4) Airway maintenance. 5) Oxygen administration to main PaO2 or tc PO2 of 60--80 mmHg. 6) Artificial ventilation by CPAP or IMV and 7) The specific drug therapy includes indomethacin for PDA associated with IRDS, Tolazoline for the fetal circulation syndrome, and Xanthine derivatives for primary apnea. 8) However, improvement by exchange transfusion has been contro-versial. On the other hand, in the type II RDS which has a relatively good prognosis, the intact survival can be expected by means of the proper management of general condition and respiration. In MAS, pneumothorax, pneumomediastinum and severe asphyxia, the proper resuscitation, oxygen administration should be given according to several conditions, especially the degree of hypoxia. The peritoneal dialysis can be lifesaving in case of severe renal impairment with RD. As the respiratory distress in the newborn is very frequent in its occurrence and death rate, its proper management is expected to result in the decrease in the newborn death rate in Hokkaido (8.1--6.6 per 1,000 live births) and the increase in the survival rate without any handicap, particularly if hospitals in each Hokkaido district give the newborn medical care more intensively than at present.
1)呼吸系统疾病——肺透明膜病(IRDS)、Ⅱ型呼吸窘迫综合征、新生儿窒息和胎粪吸入综合征等;2)贫血、先天性心脏病;3)中枢神经系统疾病;4)代谢性疾病。其中,肺透明膜病因缺乏肺表面活性物质和呼吸中枢不成熟,死亡率很高,在预防和呼吸管理方面存在许多难题。其呼吸管理要点如下:1)评估动脉氧合水平——这是最重要的一点。如今,使用经皮氧电极可以连续监测氧合情况。2)了解呼吸暂停的生理机制与管理方法,并监测心率和呼吸。3)通过静脉输液纠正酸中毒和贫血,并提供营养支持。4)维持气道通畅。5)给予氧气使动脉血氧分压(PaO2)或经皮血氧分压(tc PO2)维持在60 - 80 mmHg。6)采用持续气道正压通气(CPAP)或间歇指令通气(IMV)进行人工通气;7)特效药物治疗包括:用于与肺透明膜病相关的动脉导管未闭的吲哚美辛、用于胎儿循环综合征的妥拉唑啉以及用于原发性呼吸暂停的黄嘌呤衍生物。8)然而,换血疗法的疗效存在争议。另一方面,预后相对较好的Ⅱ型呼吸窘迫综合征,通过妥善管理一般情况和呼吸,有望实现完全存活。在胎粪吸入综合征、气胸、纵隔气肿和严重窒息的情况下,应根据多种情况,尤其是缺氧程度,进行适当的复苏和给氧。对于伴有呼吸窘迫的严重肾功能损害,腹膜透析可能挽救生命。由于新生儿呼吸窘迫的发生率和死亡率都很高,期望通过妥善管理,降低北海道地区的新生儿死亡率(每1000例活产中8.1 - 6.6例),提高无残疾生存率,特别是如果北海道各地区的医院比目前更积极地为新生儿提供医疗护理。